Early test: can cancer drug shrink tumors before prostate surgery?
NCT ID NCT01804712
Summary
This small, early-stage study tested whether giving the drug rituximab before prostate removal surgery could reduce certain immune cells inside prostate tumors. Eight men with high-risk prostate cancer received four weekly doses of rituximab before their scheduled surgery. Researchers compared tumor samples taken before and after treatment to see if the drug changed the tumor's immune environment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moores UCSD Cancer Center
La Jolla, California, 92093-0698, United States
Conditions
Explore the condition pages connected to this study.